X |
Filing Date |
Trade Date |
Ticker |
Company Name | Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-03-30 | M | Macy'S, Inc. | Bron Olivier | CEO, Bloomingdale's | S - Sale+OE | $17.74 | -3,051 | 15,672 | -16% | -$54,132 | |||||
| D | 2026-03-30 | M | Macy'S, Inc. | Preston Tracy M | EVP, CLO, Corporate Secretary | S - Sale+OE | $17.74 | -2,736 | 20,898 | -12% | -$48,536 | |||||
| D | 2026-03-30 | M | Macy'S, Inc. | Kirgan Danielle L. | EVP, CHRO | S - Sale+OE | $17.73 | -5,161 | 92,008 | -5% | -$91,516 | |||||
| D | 2026-03-30 | UTHR | United Therapeutics Corp | Rothblatt Martine A | CHAIRPERSON, CEO | S - Sale+OE | $590.59 | -9,500 | 679,872 | -1% | -$5,610,564 | |||||
| M | 2026-03-27 | EPSN | Epsilon Energy Ltd. | Stabell Jason | CEO | P - Purchase | $6.21 | +20,000 | 1,061,804 | +2% | +$124,180 | |||||
| D | 2026-03-30 | M | Macy'S, Inc. | Spring Antony | COB, CEO | S - Sale+OE | $17.73 | -27,451 | 423,256 | -6% | -$486,800 | |||||
| D | 2026-03-30 | UTHR | United Therapeutics Corp | Edgemond James | CFO, TREASURER | S - Sale+OE | $593.17 | -10,000 | 18,876 | -35% | -$5,931,683 | |||||
2026-03-31 | COP | Conocophillips | Lance Ryan Michael | COB, CEO | S - Sale | $132.71 | -113,221 | 378,481 | -23% | -$15,025,389 | ||||||
| D | 2026-03-30 | UTHR | United Therapeutics Corp | Causey Christopher | Dir | S - Sale+OE | $604.64 | -1,300 | 4,190 | -24% | -$786,032 | |||||
| D | 2026-03-27 | UTHR | United Therapeutics Corp | Rothblatt Martine A | CHAIRPERSON, CEO | S - Sale+OE | $526.96 | -9,500 | 679,872 | -1% | -$5,006,100 | |||||
2026-03-27 | HERZ | Herzfeld Credit Income Fund, Inc | Herzfeld Thomas J | Chairman of the Advisor | P - Purchase | $15.50 | +2,974 | 193,638 | +2% | +$46,097 | ||||||
2026-03-27 | MSIF | Msc Income Fund, Inc. | Marks Nataly Michelle | Dir | P - Purchase | $12.61 | +1,000 | 1,000 | New | +$12,610 | ||||||
2026-03-30 | USFD | Us Foods Holding Corp. | Locascio Dirk J. | EVP, CFO | S - Sale | $91.19 | -20,000 | 205,547 | -9% | -$1,823,800 | ||||||
2026-03-30 | RAPP | Rapport Therapeutics, Inc. | Gault Cheryl | COO | S - Sale | $28.19 | -10,000 | 159,914 | -6% | -$281,857 | ||||||
2026-03-30 | ASMB | Assembly Biosciences, Inc. | Bjorkquist Jeanette M | PFO, PAO | S - Sale | $26.69 | -328 | 11,089 | -3% | -$8,755 | ||||||
2026-03-31 | CYTK | Cytokinetics Inc | Callos Andrew | EVP, Chief Commercial Officer | S - Sale | $65.00 | -3,639 | 66,004 | -5% | -$236,535 | ||||||
2026-03-30 | ASMB | Assembly Biosciences, Inc. | White Nicole S | Chief Manufacturing Officer | S - Sale | $26.69 | -197 | 37,477 | -1% | -$5,258 | ||||||
2026-02-20 | FMBH | First Mid Bancshares, Inc. | Wolak Stas R | EVP Chief Retail Banking Ofc. | S - Sale | $43.67 | -430 | 3,630 | -11% | -$18,778 | ||||||
2026-03-30 | PLRZ | Polyrizon Ltd. | Carmel Liron | Dir | S - Sale | $11.00 | -100 | 4,069 | -2% | -$1,100 | ||||||
2026-03-30 | PLRZ | Polyrizon Ltd. | Izraeli Tomer | CEO | S - Sale | $10.90 | -3,900 | 32,012 | -11% | -$42,510 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |